Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicentre, Randomised, Assessor Blinded Study Comparing the Efficacy, Including Patient Reported Outcomes of Two Different Daily gekoTM Treatment Durations in Conjunction With Standard Care, With Each Other and to Standard Care Alone, in Patients With Venous Leg Ulcers

NCT03396731 is registered in ClinicalTrials.gov with Firstkind Ltd as lead sponsor.

NCT NCT03396731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicentre, Randomised, Assessor Blinded Study Comparing the Efficacy, Including Patient Reported Outcomes of Two Different Daily gekoTM Treatment Durations in Conjunction With Standard Care, With Each Other and to Standard Care Alone, in Patients With Venous Leg Ulcers
Lead sponsor
Firstkind Ltd
Phase
Not applicable
Overall status
Completed
Start date
April 24, 2018
Completion date
August 9, 2022
Enrollment
171 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

leg ulcer, leg ulcers venous, venous leg ulcer, wound, wound leg